Worthington Mark
SEC insider (Form 3/4/5 filer). CIK 0001861464. GENERAL COUNSEL and CCO at LeonaBio, Inc. (LONA). 18 reported Form 4/5 transactions since Sep 2024; latest on Apr 9, 2026. Located in BOTHELL, WA.
Companies Worthington Mark has filed insider reports for
- LeonaBio, Inc. (LONA): Officer, GENERAL COUNSEL and CCO
Worthington Mark
CIK: 0001861464
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LeonaBio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Apr 9, 2026LONA
LeonaBio, Inc.
AwardDirectStock Option (Right to Buy)
300K shares- - Mar 4, 2026LONA
LeonaBio, Inc.
SaleDirect1.3K shares at avg. $5.37$7K - Mar 3, 2026LONA
LeonaBio, Inc.
ExerciseDirect5.7K shares- - Jan 2, 2026ATHA
Athira Pharma, Inc.
SaleDirect876 shares at avg. $6.88$6K - Dec 31, 2025ATHA
Athira Pharma, Inc.
ExerciseDirect3.7K shares- - Dec 24, 2025ATHA
Athira Pharma, Inc.
AwardDirectStock Option (Right to Buy)
34.4K shares- - Jul 1, 2025ATHA
Athira Pharma, Inc.
SaleDirect8.5K shares at avg. $0.29$3K - Jun 30, 2025ATHA
Athira Pharma, Inc.
ExerciseDirect36.7K shares- - Mar 3, 2025ATHA
Athira Pharma, Inc.
AwardDirectRestricted Stock Units
57.3K shares- - Mar 3, 2025ATHA
Athira Pharma, Inc.
AwardDirectStock Option (Right to Buy)
85.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 9, 2026 | LONA LeonaBio, Inc. | Award Stock Option (Right to Buy) | 300,000 | - | - | Direct |
| Mar 4, 2026 | LONA LeonaBio, Inc. | Sale | 1,328 | $5.37 | $7,131 | Direct |
| Mar 3, 2026 | LONA LeonaBio, Inc. | Exercise | 5,726 | - | $0 | Direct |
| Jan 2, 2026 |  ATHA Athira Pharma, Inc. | Sale | 876 | $6.88 | $6,027 | Direct |
| Dec 31, 2025 | ATHA Athira Pharma, Inc. | Exercise | 3,667 | - | $0 | Direct |
| Dec 24, 2025 | ATHA Athira Pharma, Inc. | Award Stock Option (Right to Buy) | 34,358 | - | - | Direct |
| Jul 1, 2025 | ATHA Athira Pharma, Inc. | Sale | 8,526 | $0.29 | $2,502 | Direct |
| Jun 30, 2025 | ATHA Athira Pharma, Inc. | Exercise | 36,666 | - | - | Direct |
| Mar 3, 2025 | ATHA Athira Pharma, Inc. | Award Restricted Stock Units | 57,263 | - | - | Direct |
| Mar 3, 2025 | ATHA Athira Pharma, Inc. | Award Stock Option (Right to Buy) | 85,895 | - | - | Direct |
1-10 of 18 transactions